Hua Yuan et al. further confirmed ACSL4's central role of ACSL4 in ferroptosis, suggesting its potential as a therapeutic target for cancer (through ferroptosis induction) or neurodegenerative diseases (via ferroptosis inhibition) [17]. The gene discussed is ACSL4; the disease is cancer.